2017. COMPARATIVE PHARMACOECONOMIC EVALUATION OF THE USE OF AFATINIB AND GEFITINIB IN THERAPY FOR LUNG CANCER. Voprosy onkologii. 63, 1 (Jan. 2017), 38–51. DOI:https://doi.org/10.37469/0507-3758-2017-63-1-38-51.